
David
385 posts

David
@RealLeDave
UBC BMgmt. Trekkie🖖. EV enthusiast. Ally. 🇨🇦. Heavily invested in AUPH since 2019 🚨Apologies if you followed me before I started only posting about stocks











$AUPH It’s time to turn the Greenleaf page. He added no value before, and there’s no reason to believe he will going forward — except to continue taking free shares and riding the wave.





5 Small Caps growth under $10 Billion: $HIMS - One of the cheapest companies right now, they just hit 2 million subscribers and are expanding to provide better services. The company is profitable (Undervalued). $TMDX - The liver transplant is doing incredibly well in the US with more than 10k transplants a year. TMDX dominates this market, and liver transplants account for 60% of the company's revenue (Undervalued). $OSCR - Health insurance. An insider bought $40 million worth of shares, and the brother of the owner is part of Trump's family. $MRX - The company offers comprehensive execution and clearing services for exchange-traded derivatives. They have direct access to major exchanges like the London Metal Exchange. The company is profitable. $GENK - Korean BBQ restaurant. The company is still expanding and growing, and the company makes a profit. It's worth keeping on your watchlist. Mid cap growth under $20 billion: $ULTA has over 1,200 shops in the US, with 70% of the revenue coming from cosmetics and skin care, which are products women use daily. 100% of its market is in the US. The company has no debt and has maintained a 20% ROIC since 2009. It is undervalued and oversold.

Aurinia Commends 2024 Updated ACR Guidelines for Screening, Treatment, and Management of Lupus Nephritis. Learn more: auriniapharma.com/investors-and-…











